Susquehanna International Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $414K | Sell |
|
|||||
|
2025
Q2 | $894K | Buy |
|
|||||
|
2025
Q1 | $439K | Buy |
|
|||||
|
2024
Q4 | $89.2K | Sell |
|
|||||
|
2024
Q3 | $253K | Sell |
|
|||||
|
2024
Q2 | $1.12M | Buy |
|
|||||
|
2024
Q1 | $515K | Buy |
|
|||||
|
2023
Q4 | $118K | Sell |
|
|||||
|
2023
Q3 | $189K | Sell |
|
|||||
|
2023
Q2 | $419K | Buy |
|
|||||
|
2023
Q1 | $496K | Sell |
|
|||||
|
2022
Q4 | $839K | Buy |
|
|||||
|
2022
Q3 | $1.37M | Buy |
|
|||||
|
2022
Q2 | $708K | Sell |
|
|||||
|
2022
Q1 | $2.27M | Buy |
|
|||||
|
2021
Q4 | $2.43M | Buy |
|
|||||
|
2021
Q3 | $2.06M | Buy |
|
|||||
|
2021
Q2 | $2.44M | Sell |
|
|||||
|
2021
Q1 | $3.14M | Buy |
|
|||||
|
2020
Q4 | $2.54M | Buy |
|
|||||
|
2020
Q3 | $1.13M | Sell |
|
|||||
|
2020
Q2 | $2.16M | Sell |
|
|||||
|
2020
Q1 | $3.88M | Buy |
|
|||||
|
2019
Q4 | $2.41M | Sell |
|
|||||
|
2019
Q3 | $3.45M | Buy |
|
|||||
|
2019
Q2 | $2.65M | Sell |
|
|||||
|
2019
Q1 | $4.83M | Buy |
|
|||||
|
2018
Q4 | $828K | Sell |
|
|||||
|
2018
Q3 | $1.07M | Sell |
|
|||||
|
2018
Q2 | $4.13M | Buy |
|
|||||
|
2018
Q1 | $1.24M | Sell |
|
|||||
|
2017
Q4 | $4.7M | Sell |
|
|||||
|
2017
Q3 | $5.41M | Sell |
|
|||||
|
2017
Q2 | $7.9M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $6.37M | Buy |
|
|||||
|
2016
Q3 | $2.83M | Buy |
|
|||||
|
2016
Q2 | $2.07M | Sell |
|
|||||
|
2016
Q1 | $3.23M | Sell |
|
|||||
|
2015
Q4 | $5.39M | Sell |
|
|||||
|
2015
Q3 | $10.4M | Sell |
|
|||||
|
2015
Q2 | $27.8M | Buy |
|
|||||
|
2015
Q1 | $2.04M | Buy |
|
|||||
|
2014
Q4 | $460K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $4.68M | Buy |
|